Clarification Regarding Potential Collaborations
Scientific institutions like CERN and the US National Institute of Standards of Technology (NIST) actively seek to partner with academia and industry. Scientists from Phase Holographic Imaging (PHI) have met both institutions on several occasions to discuss the benefits of PHI’s non-invasive imaging technology within regenerative medicine and biomanufacturing. However, no partnerships have yet been established between PHI and these two institutions.
The above information is provided to mitigate any misinterpretation of the information unintentionally made publicly after a PHI presentation at a CERN Knowledge Transfer Seminar held on March 27, 2023. In the released information, it was stated that CERN and NIST are pending partners to PHI.
Links
For additional information, please contact:
Patrik Eschricht
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis
Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.